CCL2 and neoplasm: For example, tumor-associated NK cells are shown to downregulate activating receptors and become less cytotoxic [20, 21] and downregulation of essential chemokines like CCL2 can prevent NK cell trafficking to the site of a developing tumor [22, 23].